SecBot SecBot
Institutional Cluster

KYMR

Kymera Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed14d 5h ago
Institutional cluster: 5 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

The cluster is small in dollar terms and lacks insider corroboration, but the unanimous buying by asset managers may reflect growing conviction ahead of the KT-621 Phase 2b readout due by year-end 2026. Monitor the topline data release and any subsequent larger institutional moves in Q4 2026 filings.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$127.09
T+0 close · Nov 2, 2026 · via day close
Latest settled
+7.51%
T+5 · $136.64 · next T+20 in 15d
Vs SPY
+8.10%
α at T+5
Latest observation
+1.12%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $127.09entry
  2. T+1 · 13d ago +7.21%α +5.56% · $136.25
  3. T+5 · 7d ago +7.51%α +8.10% · $136.64
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five institutional asset managers added to their Kymera Therapeutics positions in Q3 2026, with aggregate buying of $1.5M versus negligible selling of $16K. The cluster follows positive Phase 1 data for KT-579 and the upcoming KT-621 Phase 2b readout, though the dollar amounts are small relative to the $10.2B market cap and the 45-day reporting lag limits timeliness.

Key Financial Metrics

Direction
accumulating
Buy Value
$3.2M
Sell Value
$16.0K
Net Flow
$1.5M

Institutional Positions

Net institutional flow: $1.5M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
Mirae Asset Global Investments Co.ADD+25%$514.0K$92.0K
Strs OhioADD+78.3%$1.2M$508.0K
Principal Financial GroupADD+85.4%$867.0K$387.0K
Nisa Investment AdvisorsADD+45.9%$232.0K$69.0K
AssetmarkDOUBLED+48437.5%$434.0K$433.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Farther Finance AdvisorsNEAR_EXIT-75.8%$20.0K-$16.0K

Key Facts

  • 5 institutional buyers added $1.5M in net new holdings during Q3 2026
  • 1 seller reduced holdings by $16K (near-exit)
  • All buyers are asset managers (no activist or hedge fund activity)
  • No open-market insider buying corroborates the cluster (confluence score 9/100)
  • Q3 2026 earnings reported 5 days ago showed no revenue and a wider net loss of $132M
  • Positive Phase 1 data for KT-579 and upcoming KT-621 Phase 2b topline data by year-end 2026

Financial Impact

5 institutions accumulated $1.5M in new positions while 1 reduced holdings by $16K; total net buying of $1.5M represents ~0.015% of market cap

institutional ownership

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • No revenue and widening losses ($132M net loss in Q3 2026) raise fundamental risk
  • Cluster is dominated by small asset managers; no large hedge fund or activist participation
  • Confluence score of 9/100 indicates no insider buying to reinforce the signal

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (30 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-KYMR-2026-Q3

Track record

37 reports on KYMR

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 9 of 14 went positive at some point.

Filters
  1. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Viewing Entry $127.09 settles Dec 2
  2. Oct 29, 202618d ago 8-K Neutral 5/10 No price data
  3. Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 settles Nov 27
  4. Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 settles Nov 27
  5. Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 settles Nov 25
  6. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 settles Nov 25
  7. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 settles Nov 20
  8. Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 ▲ +12.47% +13.07% vs SPY
  9. Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 ▲ +7.60% +10.88% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 ▲ +12.59% +13.44% vs SPY
Showing 10 of 37

US Market Status

Market Closed · Opens in 8h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026